Gastric cancer (GC) Programs in Pharmaceutical Benefits Scheme (PBS) 012-18051116
This document outlines details of PBS-subsidised trastuzumab for patients with gastric cancer (GC).
GC and listing dates
Advanced GC refers to metastatic (Stage IV) HER2 positive adenocarcinoma of the stomach or gastro-oesophageal junction.
Listing dates:
- trastuzumab - 1 January 2016
Enquiries
Transfer enquiries about prescription arrangements to the PBS Complex Drugs Programs team and choose the option relevant to the condition treated.
The Resources page contains links to contact details, item and restriction codes, the PBS schedule and the Services Australia website.
Related links
Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)